Sign Up to like & get
recommendations!
0
Published in 2020 at "Endocrinology"
DOI: 10.1158/1538-7445.am2020-4331
Abstract: Background: Current risk stratification models in prostate cancer (PC) have been based on clinical and pathological variables. Beyond serum prostate-specific antigen (PSA) concentration measurements, there remain few new biomarkers to help identify patients at risk…
read more here.
Keywords:
nuclear size;
prostate cancer;
size;
circulating tumor ... See more keywords